Absorption and excretion of suprofen in rats. 1983

Y Mori, and F Yokoya, and K Toyoshi, and S Baba, and Y Sakai

DL-2-(4-(2-Thienylcarbonyl)phenyl)propionic acid (suprofen, S) was rapidly absorbed in rats after oral administration. Blood levels after a single oral dose of 2, 10, 50, or 100 mg/kg of 3H-S reached maxima within 30 min and were dose-dependent. The major portion of the drug was shown to be absorbed from the upper part of the small intestine and a portion from the stomach. The radioactivity in rat plasma was extensively bound to the plasma protein in vivo; this was found to be unchanged S and four metabolites. Elimination of S and its metabolites from blood was rapid; 3H was mostly excreted in the urine and feces within 24 hr after oral administration of 3H-S. No significant amounts of 14CO2 were excreted in expired air after administration of 14C-S. Rat urine contained S and four metabolites found in rat plasma, accounting for about 60% of the urinary radioactivity. After rats with biliary fistulas were given an oral dose of 2 mg/kg of 3H-S, 41% of the dose was excreted in the bile during 48 hr; there was significant enterohepatic circulation. When single or 21 consecutive daily doses of 3H-S were administered to rats, the blood levels after the multiple doses were higher than those after a single dose but no significant difference was found in excretion of 3H.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D010666 Phenylpropionates Derivatives of 3-phenylpropionic acid, including its salts and esters.
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D013496 Suprofen An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It inhibits prostaglandin synthesis and has been proposed as an anti-arthritic. R-25061,TN-762,R 25061,R25061,TN 762,TN762

Related Publications

Y Mori, and F Yokoya, and K Toyoshi, and S Baba, and Y Sakai
December 1995, The Journal of pharmacy and pharmacology,
Y Mori, and F Yokoya, and K Toyoshi, and S Baba, and Y Sakai
June 1975, Archives internationales de pharmacodynamie et de therapie,
Y Mori, and F Yokoya, and K Toyoshi, and S Baba, and Y Sakai
January 1989, Toxicology and applied pharmacology,
Y Mori, and F Yokoya, and K Toyoshi, and S Baba, and Y Sakai
June 1984, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
Y Mori, and F Yokoya, and K Toyoshi, and S Baba, and Y Sakai
January 1984, IARC scientific publications,
Y Mori, and F Yokoya, and K Toyoshi, and S Baba, and Y Sakai
January 1978, Acta pharmaceutica Hungarica,
Y Mori, and F Yokoya, and K Toyoshi, and S Baba, and Y Sakai
April 1966, British journal of industrial medicine,
Y Mori, and F Yokoya, and K Toyoshi, and S Baba, and Y Sakai
January 1968, Acta poloniae pharmaceutica,
Y Mori, and F Yokoya, and K Toyoshi, and S Baba, and Y Sakai
February 1974, Toxicology and applied pharmacology,
Y Mori, and F Yokoya, and K Toyoshi, and S Baba, and Y Sakai
January 1986, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie,
Copied contents to your clipboard!